sec filing
LE
NASDAQ · LEXX
Lexaria Bioscience Corp.
Healthcare · Biotechnology
$3.10
Up+$0.85 (+27.30%)
Updated Sep 17, 2026, 4:44 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 22.39M
- P/E ratio
- -1.99
- Dividend yield
- 0.00%
- 52-week range
- $0.52 – $14.37
- Volume
- 150.4K
- Avg. volume
- 572.75K
Price performance
LEXX price history
1M range · 20 trading sessions · Daily adjusted prices
LEXX closed at $3.10 after 20 trading sessions, down 73.11% for the selected period.
- Last close
- $3.10
- Period change
- -73.11%
- Period low
- $3.10
- Period high
- $14.15
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $3.28 | $3.47 | $2.8001 | $3.095 | 150.4K |
| Sep 15, 2026 | $3.54 | $3.9316 | $2.98 | $3.21 | 123.68K |
| Sep 14, 2026 | $3.98 | $4.15 | $3.14 | $3.55 | 178.91K |
| Sep 11, 2026 | $4.15 | $4.72 | $3.645 | $3.97 | 197.06K |
| Sep 10, 2026 | $7.00 | $7.50 | $4.04 | $4.05 | 226.22K |
| Sep 9, 2026 | $9.44 | $9.52 | $6.405 | $6.60 | 74.4K |
| Sep 8, 2026 | $11.09 | $11.09 | $8.81 | $9.37 | 122.23K |
| Sep 4, 2026 | $12.26 | $14.37 | $12.26 | $14.15 | 22.43K |
| Sep 3, 2026 | $13.33 | $13.93 | $12.25 | $12.32 | 74.77K |
| Sep 2, 2026 | $12.63 | $13.61 | $12.40 | $13.205 | 40.95K |
| Sep 1, 2026 | $11.13 | $12.89 | $11.13 | $12.475 | 65.45K |
| Aug 31, 2026 | $10.30 | $12.20 | $10.30 | $11.28 | 359.55K |
| Aug 28, 2026 | $11.42 | $12.475 | $10.35 | $10.35 | 61.91K |
| Aug 27, 2026 | $10.97 | $11.78 | $10.24 | $11.68 | 505.65K |
| Aug 26, 2026 | $11.70 | $11.90 | $11.00 | $11.04 | 5.23K |
| Aug 25, 2026 | $10.75 | $11.60 | $10.60 | $11.60 | 12.33K |
| Aug 24, 2026 | $10.96 | $11.10 | $10.41 | $10.54 | 14.94K |
| Aug 21, 2026 | $11.38 | $11.5299 | $10.80 | $10.915 | 8.92K |
| Aug 20, 2026 | $11.96 | $12.8858 | $11.235 | $11.27 | 67.11K |
| Aug 19, 2026 | $11.93 | $11.98 | $11.0569 | $11.51 | 130.17K |
Latest LEXX news
The latest Smart Investors Daily articles mentioning LEXX.
Stock researchCompany · Financials
Loading stock research…

